Difference in Serological Marker Profile of Fontan Patients With Decompensated Heart Failure

Journal of Cardiac Failure - United States
doi 10.1016/j.cardfail.2019.07.544
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Effect of Nesiritide in Patients With Acute Decompensated Heart Failure

New England Journal of Medicine
Medicine
2011English

Endothelial Cell Activation in Patients With Decompensated Heart Failure

Circulation
Cardiovascular MedicinePhysiologyCardiology
2005English

Cognitive Status in Patients Hospitalized With Acute Decompensated Heart Failure

American Heart Journal
Cardiovascular MedicineCardiology
2014English

Prothrombin Time as a Novel Marker for Congestion in Patients With Acute Decompensated Heart Failure Not Taking Anticoagulants

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2015English

Hemodilution After Initial Treatment in Patients With Acute Decompensated Heart Failure

International Heart Journal
MedicineCardiovascular MedicineCardiology
2018English

Role of Ischemia-Modified Albumin in Patients With Acute Decompensated Heart Failure

Anatolian journal of cardiology
Cardiovascular MedicineCardiology
2015English

Care of the Lower Extremities in Patients With Acute Decompensated Heart Failure

Critical Care Nurse
MedicineCritical Care Nursing
2011English

Managing Patients With Rapid Atrial Fibrillation and Decompensated Heart Failure

Circulation. Heart failure
MedicineCardiovascular MedicineCardiology
2009English

Delays in Seeking Medical Care in Hospitalized Patients With Decompensated Heart Failure

American Journal of Medicine
Medicine
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy